PDE4A and colorectal carcinoma: In this study, we used a selective inhibitor of all PDE4 sub-families, rolipram [9,14,16] or PDE4B2-shRNAs, and found that rolipram and PDE4B2-shRNAs revert the disorganization of CRC into the normal physiologic state of the epithelial cell in 3 DC.